Global Human Plasma Products and Derivatives Market Research Report 2023
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
According to QYResearch’s new survey, global Human Plasma Products and Derivatives market is projected to reach US$ 50750 million in 2029, increasing from US$ 30330 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Plasma Products and Derivatives market research.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Plasma Products and Derivatives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Human Plasma Products and Derivatives market is projected to reach US$ 50750 million in 2029, increasing from US$ 30330 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Plasma Products and Derivatives market research.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Plasma Products and Derivatives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
- Hospital
- Retail Pharmacy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Plasma Products and Derivatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Plasma Products and Derivatives Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Human Plasma Products and Derivatives Market Perspective (2018-2029)
2.2 Human Plasma Products and Derivatives Growth Trends by Region
2.2.1 Global Human Plasma Products and Derivatives Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Plasma Products and Derivatives Historic Market Size by Region (2018-2023)
2.2.3 Human Plasma Products and Derivatives Forecasted Market Size by Region (2024-2029)
2.3 Human Plasma Products and Derivatives Market Dynamics
2.3.1 Human Plasma Products and Derivatives Industry Trends
2.3.2 Human Plasma Products and Derivatives Market Drivers
2.3.3 Human Plasma Products and Derivatives Market Challenges
2.3.4 Human Plasma Products and Derivatives Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Plasma Products and Derivatives Players by Revenue
3.1.1 Global Top Human Plasma Products and Derivatives Players by Revenue (2018-2023)
3.1.2 Global Human Plasma Products and Derivatives Revenue Market Share by Players (2018-2023)
3.2 Global Human Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Plasma Products and Derivatives Revenue
3.4 Global Human Plasma Products and Derivatives Market Concentration Ratio
3.4.1 Global Human Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Plasma Products and Derivatives Revenue in 2022
3.5 Human Plasma Products and Derivatives Key Players Head office and Area Served
3.6 Key Players Human Plasma Products and Derivatives Product Solution and Service
3.7 Date of Enter into Human Plasma Products and Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HUMAN PLASMA PRODUCTS AND DERIVATIVES BREAKDOWN DATA BY TYPE
4.1 Global Human Plasma Products and Derivatives Historic Market Size by Type (2018-2023)
4.2 Global Human Plasma Products and Derivatives Forecasted Market Size by Type (2024-2029)
5 HUMAN PLASMA PRODUCTS AND DERIVATIVES BREAKDOWN DATA BY APPLICATION
5.1 Global Human Plasma Products and Derivatives Historic Market Size by Application (2018-2023)
5.2 Global Human Plasma Products and Derivatives Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Human Plasma Products and Derivatives Market Size (2018-2029)
6.2 North America Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Plasma Products and Derivatives Market Size by Country (2018-2023)
6.4 North America Human Plasma Products and Derivatives Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Human Plasma Products and Derivatives Market Size (2018-2029)
7.2 Europe Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Plasma Products and Derivatives Market Size by Country (2018-2023)
7.4 Europe Human Plasma Products and Derivatives Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Plasma Products and Derivatives Market Size (2018-2029)
8.2 Asia-Pacific Human Plasma Products and Derivatives Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2018-2023)
8.4 Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Human Plasma Products and Derivatives Market Size (2018-2029)
9.2 Latin America Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Plasma Products and Derivatives Market Size by Country (2018-2023)
9.4 Latin America Human Plasma Products and Derivatives Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Plasma Products and Derivatives Market Size (2018-2029)
10.2 Middle East & Africa Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2018-2023)
10.4 Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Human Plasma Products and Derivatives Introduction
11.1.4 Takeda Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Human Plasma Products and Derivatives Introduction
11.2.4 CSL Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Human Plasma Products and Derivatives Introduction
11.3.4 Grifols Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Human Plasma Products and Derivatives Introduction
11.4.4 Octapharma Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Human Plasma Products and Derivatives Introduction
11.5.4 Kedrion Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Human Plasma Products and Derivatives Introduction
11.6.4 LFB Group Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Human Plasma Products and Derivatives Introduction
11.7.4 Biotest Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Human Plasma Products and Derivatives Introduction
11.8.4 BPL Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Detail
11.9.2 RAAS Business Overview
11.9.3 RAAS Human Plasma Products and Derivatives Introduction
11.9.4 RAAS Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Detail
11.10.2 CBPO Business Overview
11.10.3 CBPO Human Plasma Products and Derivatives Introduction
11.10.4 CBPO Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Detail
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Human Plasma Products and Derivatives Introduction
11.11.4 Hualan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Detail
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Human Plasma Products and Derivatives Introduction
11.12.4 Tiantan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Detail
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Human Plasma Products and Derivatives Introduction
11.13.4 Shuanglin Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Detail
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Human Plasma Products and Derivatives Introduction
11.14.4 Boya Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Detail
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Human Plasma Products and Derivatives Introduction
11.15.4 Yuanda Shuyang Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Detail
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Human Plasma Products and Derivatives Introduction
11.16.4 Weiguang Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Detail
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Human Plasma Products and Derivatives Introduction
11.17.4 Nanyue Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Detail
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Human Plasma Products and Derivatives Introduction
11.18.4 KM Biologics Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.18.5 KM Biologics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Plasma Products and Derivatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Plasma Products and Derivatives Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Human Plasma Products and Derivatives Market Perspective (2018-2029)
2.2 Human Plasma Products and Derivatives Growth Trends by Region
2.2.1 Global Human Plasma Products and Derivatives Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Plasma Products and Derivatives Historic Market Size by Region (2018-2023)
2.2.3 Human Plasma Products and Derivatives Forecasted Market Size by Region (2024-2029)
2.3 Human Plasma Products and Derivatives Market Dynamics
2.3.1 Human Plasma Products and Derivatives Industry Trends
2.3.2 Human Plasma Products and Derivatives Market Drivers
2.3.3 Human Plasma Products and Derivatives Market Challenges
2.3.4 Human Plasma Products and Derivatives Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Human Plasma Products and Derivatives Players by Revenue
3.1.1 Global Top Human Plasma Products and Derivatives Players by Revenue (2018-2023)
3.1.2 Global Human Plasma Products and Derivatives Revenue Market Share by Players (2018-2023)
3.2 Global Human Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Plasma Products and Derivatives Revenue
3.4 Global Human Plasma Products and Derivatives Market Concentration Ratio
3.4.1 Global Human Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Plasma Products and Derivatives Revenue in 2022
3.5 Human Plasma Products and Derivatives Key Players Head office and Area Served
3.6 Key Players Human Plasma Products and Derivatives Product Solution and Service
3.7 Date of Enter into Human Plasma Products and Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HUMAN PLASMA PRODUCTS AND DERIVATIVES BREAKDOWN DATA BY TYPE
4.1 Global Human Plasma Products and Derivatives Historic Market Size by Type (2018-2023)
4.2 Global Human Plasma Products and Derivatives Forecasted Market Size by Type (2024-2029)
5 HUMAN PLASMA PRODUCTS AND DERIVATIVES BREAKDOWN DATA BY APPLICATION
5.1 Global Human Plasma Products and Derivatives Historic Market Size by Application (2018-2023)
5.2 Global Human Plasma Products and Derivatives Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Human Plasma Products and Derivatives Market Size (2018-2029)
6.2 North America Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Plasma Products and Derivatives Market Size by Country (2018-2023)
6.4 North America Human Plasma Products and Derivatives Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Human Plasma Products and Derivatives Market Size (2018-2029)
7.2 Europe Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Plasma Products and Derivatives Market Size by Country (2018-2023)
7.4 Europe Human Plasma Products and Derivatives Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Human Plasma Products and Derivatives Market Size (2018-2029)
8.2 Asia-Pacific Human Plasma Products and Derivatives Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2018-2023)
8.4 Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Human Plasma Products and Derivatives Market Size (2018-2029)
9.2 Latin America Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Plasma Products and Derivatives Market Size by Country (2018-2023)
9.4 Latin America Human Plasma Products and Derivatives Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Human Plasma Products and Derivatives Market Size (2018-2029)
10.2 Middle East & Africa Human Plasma Products and Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2018-2023)
10.4 Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Human Plasma Products and Derivatives Introduction
11.1.4 Takeda Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Human Plasma Products and Derivatives Introduction
11.2.4 CSL Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Human Plasma Products and Derivatives Introduction
11.3.4 Grifols Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Human Plasma Products and Derivatives Introduction
11.4.4 Octapharma Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Human Plasma Products and Derivatives Introduction
11.5.4 Kedrion Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Human Plasma Products and Derivatives Introduction
11.6.4 LFB Group Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Human Plasma Products and Derivatives Introduction
11.7.4 Biotest Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Human Plasma Products and Derivatives Introduction
11.8.4 BPL Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Detail
11.9.2 RAAS Business Overview
11.9.3 RAAS Human Plasma Products and Derivatives Introduction
11.9.4 RAAS Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Detail
11.10.2 CBPO Business Overview
11.10.3 CBPO Human Plasma Products and Derivatives Introduction
11.10.4 CBPO Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Detail
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Human Plasma Products and Derivatives Introduction
11.11.4 Hualan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Detail
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Human Plasma Products and Derivatives Introduction
11.12.4 Tiantan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Detail
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Human Plasma Products and Derivatives Introduction
11.13.4 Shuanglin Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Detail
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Human Plasma Products and Derivatives Introduction
11.14.4 Boya Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Detail
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Human Plasma Products and Derivatives Introduction
11.15.4 Yuanda Shuyang Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Detail
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Human Plasma Products and Derivatives Introduction
11.16.4 Weiguang Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Detail
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Human Plasma Products and Derivatives Introduction
11.17.4 Nanyue Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Detail
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Human Plasma Products and Derivatives Introduction
11.18.4 KM Biologics Revenue in Human Plasma Products and Derivatives Business (2018-2023)
11.18.5 KM Biologics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Human Plasma Products and Derivatives Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Coagulation Factor
Table 3. Key Players of Immune Globulin
Table 4. Key Players of Albumin
Table 5. Key Players of Others
Table 6. Global Human Plasma Products and Derivatives Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Human Plasma Products and Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Human Plasma Products and Derivatives Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Human Plasma Products and Derivatives Market Share by Region (2018-2023)
Table 10. Global Human Plasma Products and Derivatives Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Human Plasma Products and Derivatives Market Share by Region (2024-2029)
Table 12. Human Plasma Products and Derivatives Market Trends
Table 13. Human Plasma Products and Derivatives Market Drivers
Table 14. Human Plasma Products and Derivatives Market Challenges
Table 15. Human Plasma Products and Derivatives Market Restraints
Table 16. Global Human Plasma Products and Derivatives Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Human Plasma Products and Derivatives Market Share by Players (2018-2023)
Table 18. Global Top Human Plasma Products and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma Products and Derivatives as of 2022)
Table 19. Ranking of Global Top Human Plasma Products and Derivatives Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Human Plasma Products and Derivatives Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Human Plasma Products and Derivatives Product Solution and Service
Table 23. Date of Enter into Human Plasma Products and Derivatives Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Plasma Products and Derivatives Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Human Plasma Products and Derivatives Revenue Market Share by Type (2018-2023)
Table 27. Global Human Plasma Products and Derivatives Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Human Plasma Products and Derivatives Revenue Market Share by Type (2024-2029)
Table 29. Global Human Plasma Products and Derivatives Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Human Plasma Products and Derivatives Revenue Market Share by Application (2018-2023)
Table 31. Global Human Plasma Products and Derivatives Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Human Plasma Products and Derivatives Revenue Market Share by Application (2024-2029)
Table 33. North America Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Human Plasma Products and Derivatives Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Human Plasma Products and Derivatives Product
Table 51. Takeda Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Human Plasma Products and Derivatives Product
Table 56. CSL Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Human Plasma Products and Derivatives Product
Table 61. Grifols Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Human Plasma Products and Derivatives Product
Table 66. Octapharma Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Human Plasma Products and Derivatives Product
Table 71. Kedrion Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Human Plasma Products and Derivatives Product
Table 76. LFB Group Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Human Plasma Products and Derivatives Product
Table 81. Biotest Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Human Plasma Products and Derivatives Product
Table 86. BPL Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Detail
Table 89. RAAS Business Overview
Table 90. RAAS Human Plasma Products and Derivatives Product
Table 91. RAAS Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Detail
Table 94. CBPO Business Overview
Table 95. CBPO Human Plasma Products and Derivatives Product
Table 96. CBPO Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Detail
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Human Plasma Products and Derivatives Product
Table 101. Hualan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Detail
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Human Plasma Products and Derivatives Product
Table 106. Tiantan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Detail
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Human Plasma Products and Derivatives Product
Table 111. Shuanglin Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Detail
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Human Plasma Products and Derivatives Product
Table 116. Boya Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Detail
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Human Plasma Products and Derivatives Product
Table 121. Yuanda Shuyang Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Detail
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Human Plasma Products and Derivatives Product
Table 126. Weiguang Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Detail
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Human Plasma Products and Derivatives Product
Table 131. Nanyue Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Detail
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Human Plasma Products and Derivatives Product
Table 136. KM Biologics Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 1. Global Human Plasma Products and Derivatives Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Coagulation Factor
Table 3. Key Players of Immune Globulin
Table 4. Key Players of Albumin
Table 5. Key Players of Others
Table 6. Global Human Plasma Products and Derivatives Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Human Plasma Products and Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Human Plasma Products and Derivatives Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Human Plasma Products and Derivatives Market Share by Region (2018-2023)
Table 10. Global Human Plasma Products and Derivatives Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Human Plasma Products and Derivatives Market Share by Region (2024-2029)
Table 12. Human Plasma Products and Derivatives Market Trends
Table 13. Human Plasma Products and Derivatives Market Drivers
Table 14. Human Plasma Products and Derivatives Market Challenges
Table 15. Human Plasma Products and Derivatives Market Restraints
Table 16. Global Human Plasma Products and Derivatives Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Human Plasma Products and Derivatives Market Share by Players (2018-2023)
Table 18. Global Top Human Plasma Products and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma Products and Derivatives as of 2022)
Table 19. Ranking of Global Top Human Plasma Products and Derivatives Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Human Plasma Products and Derivatives Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Human Plasma Products and Derivatives Product Solution and Service
Table 23. Date of Enter into Human Plasma Products and Derivatives Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Plasma Products and Derivatives Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Human Plasma Products and Derivatives Revenue Market Share by Type (2018-2023)
Table 27. Global Human Plasma Products and Derivatives Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Human Plasma Products and Derivatives Revenue Market Share by Type (2024-2029)
Table 29. Global Human Plasma Products and Derivatives Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Human Plasma Products and Derivatives Revenue Market Share by Application (2018-2023)
Table 31. Global Human Plasma Products and Derivatives Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Human Plasma Products and Derivatives Revenue Market Share by Application (2024-2029)
Table 33. North America Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Human Plasma Products and Derivatives Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Human Plasma Products and Derivatives Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Plasma Products and Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Human Plasma Products and Derivatives Market Size by Country (2024-2029) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Human Plasma Products and Derivatives Product
Table 51. Takeda Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Human Plasma Products and Derivatives Product
Table 56. CSL Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Human Plasma Products and Derivatives Product
Table 61. Grifols Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Human Plasma Products and Derivatives Product
Table 66. Octapharma Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Human Plasma Products and Derivatives Product
Table 71. Kedrion Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Human Plasma Products and Derivatives Product
Table 76. LFB Group Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Human Plasma Products and Derivatives Product
Table 81. Biotest Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Human Plasma Products and Derivatives Product
Table 86. BPL Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Detail
Table 89. RAAS Business Overview
Table 90. RAAS Human Plasma Products and Derivatives Product
Table 91. RAAS Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Detail
Table 94. CBPO Business Overview
Table 95. CBPO Human Plasma Products and Derivatives Product
Table 96. CBPO Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Detail
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Human Plasma Products and Derivatives Product
Table 101. Hualan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Detail
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Human Plasma Products and Derivatives Product
Table 106. Tiantan Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Detail
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Human Plasma Products and Derivatives Product
Table 111. Shuanglin Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Detail
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Human Plasma Products and Derivatives Product
Table 116. Boya Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Detail
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Human Plasma Products and Derivatives Product
Table 121. Yuanda Shuyang Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Detail
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Human Plasma Products and Derivatives Product
Table 126. Weiguang Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Detail
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Human Plasma Products and Derivatives Product
Table 131. Nanyue Bio Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Detail
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Human Plasma Products and Derivatives Product
Table 136. KM Biologics Revenue in Human Plasma Products and Derivatives Business (2018-2023) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Human Plasma Products and Derivatives Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Human Plasma Products and Derivatives Market Share by Type: 2022 VS 2029
Figure 3. Coagulation Factor Features
Figure 4. Immune Globulin Features
Figure 5. Albumin Features
Figure 6. Others Features
Figure 7. Global Human Plasma Products and Derivatives Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Human Plasma Products and Derivatives Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Human Plasma Products and Derivatives Report Years Considered
Figure 13. Global Human Plasma Products and Derivatives Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Human Plasma Products and Derivatives Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Plasma Products and Derivatives Market Share by Region: 2022 VS 2029
Figure 16. Global Human Plasma Products and Derivatives Market Share by Players in 2022
Figure 17. Global Top Human Plasma Products and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma Products and Derivatives as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Human Plasma Products and Derivatives Revenue in 2022
Figure 19. North America Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 21. United States Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 25. Germany Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Human Plasma Products and Derivatives Market Share by Region (2018-2029)
Figure 33. China Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 41. Mexico Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 45. Turkey Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Takeda Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 48. CSL Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 49. Grifols Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 50. Octapharma Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 51. Kedrion Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 52. LFB Group Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 53. Biotest Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 54. BPL Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 55. RAAS Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 56. CBPO Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 57. Hualan Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 58. Tiantan Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 59. Shuanglin Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 60. Boya Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 61. Yuanda Shuyang Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 62. Weiguang Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 63. Nanyue Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 64. KM Biologics Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Human Plasma Products and Derivatives Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Human Plasma Products and Derivatives Market Share by Type: 2022 VS 2029
Figure 3. Coagulation Factor Features
Figure 4. Immune Globulin Features
Figure 5. Albumin Features
Figure 6. Others Features
Figure 7. Global Human Plasma Products and Derivatives Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Human Plasma Products and Derivatives Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Human Plasma Products and Derivatives Report Years Considered
Figure 13. Global Human Plasma Products and Derivatives Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Human Plasma Products and Derivatives Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Plasma Products and Derivatives Market Share by Region: 2022 VS 2029
Figure 16. Global Human Plasma Products and Derivatives Market Share by Players in 2022
Figure 17. Global Top Human Plasma Products and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma Products and Derivatives as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Human Plasma Products and Derivatives Revenue in 2022
Figure 19. North America Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 21. United States Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 25. Germany Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Human Plasma Products and Derivatives Market Share by Region (2018-2029)
Figure 33. China Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 41. Mexico Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Human Plasma Products and Derivatives Market Share by Country (2018-2029)
Figure 45. Turkey Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Human Plasma Products and Derivatives Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Takeda Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 48. CSL Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 49. Grifols Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 50. Octapharma Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 51. Kedrion Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 52. LFB Group Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 53. Biotest Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 54. BPL Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 55. RAAS Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 56. CBPO Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 57. Hualan Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 58. Tiantan Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 59. Shuanglin Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 60. Boya Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 61. Yuanda Shuyang Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 62. Weiguang Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 63. Nanyue Bio Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 64. KM Biologics Revenue Growth Rate in Human Plasma Products and Derivatives Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
